Epigenic Therapeutics, a clinical-stage biotech company specializing in epigenetic-based drug development, has secured $60 million in a Series B funding round. The round was led
Modella AI, a leader in artificial intelligence for life sciences, announced a multi-year agreement with AstraZeneca. Under the agreement, Modella AI will provide access to
Sirius Therapeutics announced that it has successfully completed nearly $50 million Series B2 financing to advance clinical development of the Company’s novel siRNA therapeutics for
CARAai is the Leading Multi-Modal Oncology Data Cloud and Platform for a Suite of AI SaaS Solutions with NVIDIA NIM Microservices Fine-Tuned with Oncology Data
